AstraZeneca's conjugates featuring cleavable linkers of Formula (IA) for targeted drug delivery, particularly in cancer treatment.

Patentradars sammanfattning

This AstraZeneca patent application discloses conjugates incorporating cleavable linkers of Formula (IA), classified under C07H 15/203. The conjugates are designed for pharmaceutical use, particularly in oncology, enabling targeted delivery of therapeutic payloads via selectively cleavable chemical linkers. The specification also covers pharmaceutically acceptable salts, synthetic intermediates, and methods of treating diseases such as cancer using these conjugates.

AI-genererad och redaktionellt processad.